{
    "2018-05-28": [
        [
            {
                "time": "",
                "orginal_text": "【互通资金动向】北上资金连续三个月增持医药生物 爱尔眼科通化东宝成“新宠”",
                "features": {
                    "keywords": [
                        "北上资金",
                        "医药生物",
                        "爱尔眼科",
                        "通化东宝"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "豪取15板！中签者便净赚10万，是否高估了，后市怎么走？",
                "features": {
                    "keywords": [
                        "15板",
                        "中签",
                        "净赚",
                        "高估",
                        "后市"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "【海通医药】中国生物制药17-18Q1经营情况分析：研发与高增长品种驱动未来",
                "features": {
                    "keywords": [
                        "海通医药",
                        "中国生物制药",
                        "研发",
                        "高增长品种"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "四连阴后反弹在即 沪指将构筑“假头肩底”？",
                "features": {
                    "keywords": [
                        "四连阴",
                        "反弹",
                        "沪指",
                        "假头肩底"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "发改委支持国有、民营企业混改；基金继续看好医药板块",
                "features": {
                    "keywords": [
                        "发改委",
                        "国企混改",
                        "民企混改",
                        "基金",
                        "医药板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "恒瑞医药股价破百 继续创新高",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "股价破百",
                        "创新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "药品注册审评审批优化 利好创新药公司",
                "features": {
                    "keywords": [
                        "药品注册",
                        "审评审批",
                        "创新药公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "15涨停，药明康德何时到顶？总市值已达1231亿！",
                "features": {
                    "keywords": [
                        "15涨停",
                        "药明康德",
                        "总市值",
                        "到顶"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}